Bal Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

15.69

14.82

14.82

14.17

14.17

Share application money

1.39

0.94

0.94

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

78.95

71.56

63.56

51.77

62.69

Loan funds

Secured loans

125.23

98.01

98.98

93.75

96.81

Unsecured loans

-

-

-

-

-

Total

221.26

185.33

178.30

159.70

173.67

Uses of funds

Fixed assets

Gross block

95.80

82.79

78.29

75.69

70.85

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

32.73

29.89

25.64

19.56

13.91

Net block

63.07

52.90

52.65

56.14

56.94

Capital work-in-progress

-

1.16

-

0.11

0.06

Investments

8.40

8.40

8.40

7.42

7.44

Net current assets

Current assets, loans & advances

276.24

227.16

200.49

175.66

192.71

Less : current liabilities & provisions

126.44

104.29

83.24

79.62

83.48

Total net current assets

149.80

122.87

117.25

96.04

109.23

Miscellaneous expenses not written

-

-

-

-

-

Total

221.26

185.33

178.30

159.70

173.67

Notes:

Book value of unquoted investments

-

-

9.57

8.59

7.44

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

16.44

16.25

4.34

12.99

20.37

Number of equity sharesoutstanding (Lacs)

156.90

148.22

148.22

141.72

141.72